Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia

B. F. Jacobson, E. Schapkaitz, M. Mer, S. Louw, S. Haas, H. R. Buller, B. Brenner, A. T. O. Abdool-Carrim, P. de Jong, P. Hsu, D. Jankelow, M. Lebos, B. Levy, H. Radford, P. Rowji, L. Redman, M. Sussman, D. van der Jagt, P. F. Wessels, P. G. Williams

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)

Abstract

There have recently been safety concerns regarding an increased risk of vaccine-induced immune thrombotic thrombocytopenia (VITT) following administration of SARS-CoV-2 adenoviral vector vaccines. The Southern African Society of Thrombosis and Haemostasis reviewed the emerging literature on this idiosyncratic complication. A draft document was produced and revised by consensus agreement by a panel of professionals from various specialties. The recommendations were adjudicated by independent international experts to avoid local bias. We present concise, practical guidelines for the clinical management of VITT.
Original languageEnglish
Pages (from-to)535-537
Number of pages3
JournalSouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
Volume111
Issue number6
DOIs
Publication statusPublished - 2021

Cite this